Neuronetics Inc (STIM)

Currency in USD
2.430
-0.275(-10.17%)
Closed·
2.380-0.050(-2.06%)
·

STIM Earnings

Latest Release
Nov 04, 2026
EPS / Forecast
-0.02 / -0.09
Revenue / Forecast
42M / 40.43M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/12--/-0.061--/45.60M----Free Sign Up
2026/09-0.020/-0.09042.00M/40.43M+77.78%+3.88%Free Sign Up
2026/06-0.050/-0.12041.57M/40.11M+58.33%+3.64%Free Sign Up
2026/03-0.160/-0.13034.50M/34.18M-23.08%+0.94%Free Sign Up
2025/12-0.100/-0.09041.77M/40.66M-11.11%+2.73%Free Sign Up
2025/09-0.130/-0.13021.80M/37.85M0%-42.4%Free Sign Up
2025/06-0.150/-0.08038.11M/36.59M-87.5%+4.15%Free Sign Up
2025/03-0.210/-0.19031.98M/29.07M-10.53%+10.01%Free Sign Up
2024/12-0.330/-0.24022.50M/18.97M-37.5%+18.61%Free Sign Up
2024/09-0.440/-0.23018.53M/19.14M-91.3%-3.19%Free Sign Up

All numbers in USD

Neuronetics Inc Earnings Call Summary for Q3/2026

  • Neuronetics Q3 2026 beat estimates with $0.02 loss vs. $0.09 expected; revenue hit $42M vs. $40.43M forecast; shares surged 16.81% to $2.64.
  • Gross margin expanded to 52.2% from 45.9% YoY; operating income turned positive at $0.5M vs. $7.3M loss prior year, nearing profitability.
  • Greenbrook revenue jumped 20.1% to $26.2M; NeuroStar rose 1.8% to $15.8M, driven by record system sales and improved revenue cycle management.
  • Full-year revenue guidance held at $160M-$164M; gross margin raised to 49%-50%; operating expenses lowered to $92.5M-$95.5M from $95M-$100M.
  • Management expects sustained 2027 growth; preparing for FDA review of accelerated TMS protocol, Wave Neuroscience integration, and EHR rollout.
Last Updated: 2026-11-04, 10:04 a/m
Read Full Transcript

FAQ

What Is Neuronetics's Earnings Per Share (TTM)?

The Neuronetics EPS (TTM) is -0.32.

When Is The Next Neuronetics Earnings Date?

Neuronetics will release its next earnings report on Mar 09, 2027.

What Is Neuronetics’s Revenue Forecasts For Upcoming Quarters?

Neuronetics’s revenue forecast is 45.60M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.